Building Towards Universal Reference Standards for Gene Therapy & Why the Field Can’t Progress Without Them

• Navigating evolving global regulatory frameworks, differences in CMC, and requirements across regions
• Discussing ongoing initiatives and collaborations aimed at standardising CMC standards
• Strategies for overcoming them to ensure smoother global product development

Speakers:

Jonathan Campbell

British Pharmacopeia Specialist

Medicines & Healthcare Products Regulatory Agency (MHRA)